Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Memory decline among menopausal women could be next research frontier for hypnotic relaxation therapy

  • Immersed in violence: How 3-D gaming affects video game players

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • No relationship between moderate adolescent cannabis use, exam results or IQ, large study shows

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

  • Key factor in transition from moderate to problem drinking

  • A rich vocabulary can protect against cognitive impairment

  •